An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 050719
Company: CASPER PHARMA LLC

Products on NDA 050719

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
HELIDAC	BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE	262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE, TABLET, CAPSULE;ORAL	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 050719

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/15/1996	ORIG-1	Approval	Type 4 - New Combination	STANDARD	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/1996/050719lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/50719slr06ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/31/2025	SUPPL-26	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050719s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/050719Orig1s026ltr.pdf
07/08/2024	SUPPL-25	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050719s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/050719Orig1s025ltr.pdf
12/15/2021	SUPPL-24	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050719s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/050719Orig1s024ltr.pdf
03/05/2021	SUPPL-23	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050719s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/050719Orig1s023ltr.pdf
03/14/2019	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050719s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/050719Orig1s022ltr.pdf
08/11/2015	SUPPL-21	Labeling-Package Insert	Label (PDF) Letter (PDF)	Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050719s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/050719Orig1s021ltr.pdf
06/19/2012	SUPPL-20	Manufacturing (CMC)	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050719s017s020lbl.pdf
06/19/2012	SUPPL-17	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050719s017s020lbl.pdf
11/12/2009	SUPPL-15	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050719s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/050719s015ltr.pdf
06/27/2008	SUPPL-13	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050719s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050719s013ltr.pdf
07/24/2007	SUPPL-9	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/050719s009ltr.pdf
09/10/2004	SUPPL-8	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50719s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50719s008ltr.pdf
04/27/2003	SUPPL-7	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/050719s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/50719slr007ltr.pdf
12/12/2002	SUPPL-6	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/50719slr006_Helidac_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/50719slr06ltr.pdf
06/30/1999	SUPPL-5	Labeling		Label is not available on this site.
07/29/1999	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
10/30/1998	SUPPL-3	Manufacturing (CMC)		Label is not available on this site.
05/15/1998	SUPPL-2	Manufacturing (CMC)-Control	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050719s002lbl.pdf
08/28/1997	SUPPL-1	Labeling		Label is not available on this site.

Labels for NDA 050719

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/31/2025	SUPPL-26	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050719s026lbl.pdf
07/08/2024	SUPPL-25	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050719s025lbl.pdf
12/15/2021	SUPPL-24	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050719s024lbl.pdf
03/05/2021	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050719s023lbl.pdf
03/14/2019	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050719s022lbl.pdf
08/11/2015	SUPPL-21	Labeling-Package Insert	Label (PDF)	Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050719s021lbl.pdf
06/19/2012	SUPPL-20	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050719s017s020lbl.pdf
06/19/2012	SUPPL-17	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050719s017s020lbl.pdf
11/12/2009	SUPPL-15	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050719s015lbl.pdf
06/27/2008	SUPPL-13	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050719s013lbl.pdf
09/10/2004	SUPPL-8	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50719s008lbl.pdf
04/27/2003	SUPPL-7	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/050719s007lbl.pdf
12/12/2002	SUPPL-6	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/50719slr006_Helidac_lbl.pdf
05/15/1998	SUPPL-2	Manufacturing (CMC)-Control	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050719s002lbl.pdf
08/15/1996	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/1996/050719lbl.pdf

Top